A similar approach was used by Tahara et al., who used PLGA particles to deliver a nuclear factor (NF)-κB decoy oligonucleotide to the inflamed gut mucosa of IBD mice to reduce inflammation by interfering with the NF-κB activity promoting inflammation. This evidence concerns the gene NFKB1 and inflammatory bowel disease.